AbbVie Inc (NYSE:ABBV)

56.90
Data as of Oct 22
 +0.61 / +1.08%
Today’s Change
45.50
Today|||52-Week Range
60.02
+7.74%
Year-to-Date
Mylan tweaks $5bn 'inversion' deal
Oct 22 / FT.com
Benzinga's Weekend M&A Chatter
Oct 19 / Benzinga
Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breaku...
Oct 22 / Zacks.com
Long-term reforms of US tax system required to stop 'deserters'
Oct 19 / FT.com
Third Point's Daniel Loeb Tells Amgen it's Time to Break up
Oct 22 / TheStreet.com
M&A deal failure at highest since 2008
Oct 19 / FT.com
Will This Price Target Increase Help AbbVie (ABBV) Stock Today?
Oct 22 / TheStreet.com
We May Have an Investable Bottom; Smoke Always Clears: Jim Cramer's Best Blogs
Oct 18 / TheStreet.com
Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results
Oct 22 / TheStreet.com
Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?
Oct 18 / MotleyFool.com
Celgene Corporation's Earnings Preview: Pay Attention to New Kids
Oct 22 / MotleyFool.com
Infinity Pharmaceuticals' Duvelisib Fails in Mid-Stage Study - Analyst Blog
Oct 17 / Zacks.com
AbbVie and HP: corporate writing stinks and the CEO is to blame
Oct 22 / FT.com
Pfizer's AstraZeneca pursuit knocked by Shire deal collapse
Oct 17 / FT.com
AbbVie Drops Shire Deal, Announces Buyback, Ups Dividend - Analyst Blog
Oct 21 / Zacks.com
Gilead's Harvoni Receives Notice of Compliance from Canada - Analyst Blog
Oct 17 / Zacks.com
Avoid the Crowd
Oct 21 / TheStreet.com
Boxes: Checked!
Oct 17 / TheStreet.com
Notable Analyst Rating Changes 10/21: (GPOR) (ILMN) (POST) Upgraded; (ABBV) (IBM) (BH...
Oct 21 / Investing Channel
Benzinga's M&A Chatter for Thursday October 16, 2014
Oct 17 / Benzinga
#PreMarket Primer: Tuesday, October 21: China's Third Quarter Growth Disappoints
Oct 21 / Benzinga
AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb?
Oct 16 / TheStreet.com
3 Drugs Critical to Johnson & Johnson's Future
Oct 21 / MotleyFool.com
Some inversion deals may survive tax changes
Oct 16 / FT.com
European Stocks Rise as Corporate Earnings Overshadow Macro Concerns
Oct 21 / TheStreet.com
Shire (SHPG) Shares Crash on Concerns Over AbbVie Buyout - Analyst Blog
Oct 16 / Zacks.com
Must Watch Stocks For October 21, 2014
Oct 21 / Benzinga
Run for Shelter in Community Banks
Oct 16 / TheStreet.com
AbbVie Unveils $5 Billion Buyback; Blames U.S. For Failed Inversion
Oct 20 / Benzinga
Benzinga's Volume Movers
Oct 16 / Benzinga
Benzinga's M&A Chatter for Monday October 20, 2014
Oct 20 / Benzinga
Deal doers slam the brakes on
Oct 16 / FT.com
Announcement Of Termination Of Proposed AbbVie And Shire Transaction
Oct 20 / Benzinga
How Will AbbVie (ABBV) Stock React Today to Abandoned Shire Deal?
Oct 16 / TheStreet.com
AbbVie hits Treasury as Shire deal dies
Oct 20 / FT.com
AbbVie Abandons Shire Takeover Plans as Tax Benefits Recede
Oct 16 / TheStreet.com
Enanta Pharma Reports Update on Collaboration Deal with AbbVie: Will Not Exercise Opt...
Oct 20 / Benzinga
3 Reasons AbbVie's Stock Could Rise
Oct 16 / MotleyFool.com
Will Abbott Labs (ABT) Miss on Earnings This Quarter? - Analyst Blog
Oct 20 / Zacks.com
October 16 Premarket Briefing: 10 Things You Should Know
Oct 16 / TheStreet.com
3 Drugs Stocks Pushing Industry Growth
Oct 20 / TheStreet.com
European Stocks Continue Their Slide Lower; Shire Extends Losses
Oct 16 / TheStreet.com
3 Stocks I'll Buy if the Market Crashes
Oct 20 / MotleyFool.com
Stocks: 5 things to know before the open
Oct 16 / CNNMoney.com
Cramer Reviews His Top 10 List for a Market Recovery: Boxes Checked!
Oct 20 / TheStreet.com
AbbVie drops proposed $54bn Shire deal
Oct 16 / FT.com
First Detailed Look at Celgene Crohn's Disease Pill Impresses
Oct 20 / TheStreet.com
 $55 billion deal halted by tax dodge crackdown
Oct 15 / CNNMoney.com
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Oct 20 / MotleyFool.com
Hedge funds face their worst year since 2011
Oct 15 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.